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 17 
Summary 18 
Molecular epidemiology of viral infections traditionally based on the analysis of 19 
changes in individual genes or genetic markers. The analysis of the African swine fever 20 
virus (ASFV) genes encoding immunomodulatory proteins is an important tool for 21 
studying the diversity and evolution of the virus. In this work, we carried out a 22 
structural and phylogenetic analysis of the ASF virus immunomodulatory proteins 5EL 23 
(A238l gene), I14L (Dp71l gene), K11L (I329l gene). The degree of nucleotide 24 
substitutions of the ASFV concatenated genes A238l, I329l and Dp71l revealed 25 
purifying (stabilizing) selection at the nucleotide sequences level. The variability 26 
characteristic of the selected group of ASFV genes is of great interest for the genetic 27 
differences search in immunomodulatory proteins. The sequencing results of the A238l, 28 
I329l and Dp71l genes and their phylogenetic analysis showed that these genes are 29 
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conservative among a large group of ASFV genes. The I329l gene is a genetic marker of 30 
common origin. The East African strains (Genotype X) of Dp71l gene have two forms: 31 
a long (184 amino acids) and a short (from 70 to 72 amino acids) and is formed by 32 
fusion of the 13L and 14L. All ASF virus Russian isolates isolated in 2016-2017 were 33 
identical to the reference strain ASFV/Georgia/wb/2007. Characterization of variability 34 
5EL protein, I14L, K11L may be serve to identify target sites in the ASFV genome and 35 
to develop vaccines. The obtained data allow to evaluate the genetic diversity of the 36 
ASFV immunomodulatory proteins and the dynamics of their evolution, to predict the 37 
possible participation of the A238l, I329l and Dp71l genes in the virulence of various 38 
ASFV strains. 39 
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African swine fever (ASF) is a hemorrhagic deadly disease of domestic pigs and 45 
boars caused by the complex shell deoxivirus of the Asfarviridae family. Mortality in 46 
infected herds reaches 100%. The disease is transmitted from sick animals and virus 47 
carriers by alimentary, contact and transplacental [1]. The ASFV genome is a linear 48 
double-stranded DNA molecule with covalently closed ends and terminal inverted 49 
repeats (TIR) [2]. 50 
Domestic pigs of all age groups and breeds and wild boars are susceptible to the 51 
ASFV. Among the African members of the Suidae family, wild African and bush pigs, 52 
warthogs, may be infected with ASFV but without showing clinical signs. The main 53 
virus reservoir in the wild in East African countries are soft mites of the genus 54 
Ornithodoros [3]. 55 
3 
 
Depending on the virus strain, virulence and mode of infection, the observed 56 
clinical signs are diverse in a peracute, acute, subacute and chronic forms of infection 57 
[4]. The ASF epidemiology is very complex and varies depending on the geographical 58 
features of the area and susceptible species of animals (wild boar, domestic pigs, ticks) 59 
[3]. 60 
Effective means of protection against the ASFV has not yet been developed. 61 
Historical attempts to protect animals with inactivated vaccines have either failed or 62 
yielded conflicting results. Studies using attenuated vaccines have demonstrated their 63 
potential to protect pigs from experimental infection with a homologous virulent virus, 64 
but rarely against heterologous viruses [5—7]. The study of antigenic diversity among 65 
naturally occurring of ASFV isolates is of great interest for vaccine development [8]. 66 
Recent studies indicate that the virus genetic diversity determined by sequencing 67 
the major capsid protein P72 (B646l gene) is highest in Central and East Africa [3]. The 68 
high level of the ASFV genetic variability between different isolates is explained by the 69 
difference in the genome size, but most genetic variation is due to changes in the 70 
number and sequence of multigenic families members (MGF) located at both ends of 71 
the genome, where they limit the left and right variable regions (LVR and RVR, 72 
respectively) [9]. 73 
The ASFV genome contains a set of genes encoding the proteins responsible for 74 
the immune evasion mechanisms. The modulation activity range of viral proteins is very 75 
diverse and includes: inhibition of humoral response, interference with interferons, 76 
inhibition of cytokines and chemokines, evasion of cytotoxic T lymphocytes (CTLs) 77 
and natural killer cells (NKs), and control of the major histocompatibility complex 78 
(MHC I and II) function, changes in the effector function of dendritic cells and 79 
inhibition of apoptosis [10]. 80 
4 
 
The ASFV is a macrophage-tropic virus and can manipulate both innate and 81 
adaptive immune response by modulating macrophages functions. According to L. 82 
Dixon et al., several ASFV proteins have been identified which prevent the 83 
development of the host's immune defense [11]. These include the A238l gene that 84 
encodes a 5EL protein which acts to inhibit transcriptional activation of host 85 
immunomodulatory genes, K11L protein (I329l gene) acting as inhibitor of Toll-like 86 
receptors signaling pathways and I14L protein (Dp71l gene) similar to the herpes 87 
simplex virus-encoded virulence factor ICP34.5 which regulates the phosphatase 88 
activity of the host cell during infection displacing inhibitory substrates from PP1 host 89 
phosphatase and determining the range of sensitive hosts [12—14]. In addition, A238l 90 
inhibits the host calceneurin dependent pathways by directly binding calceneurin 91 
phosphatase [14]. 92 
However, not all known ASFV isolates have the same immunomodulatory 93 
activity [15]. The genetic background of these differences remains unclear. Thus, the 94 
detection of genetic markers of evolutionary variability in ASFV immunomodulating 95 
proteins will allow to study the ASFV immune evasion mechanisms.  96 
The aim of the study is to conduct a comparative analysis of nucleotide 97 
sequences of ASFV A238l, I329l and Dp71l genes involved in immune evasion. 98 
 99 
Material and methods 100 
At the first stage, the 5EL, K11L and I14L proteins variability was analyzed 101 
using the web service Protein Variability Server by Simpson method 102 
(http://www.expasy.org/proteomics) [16]. Region for which the values obtained 103 
exceeded the threshold value (0.46) were considered variable. SignalP 4.1 web server 104 
was used to predict the presence and location of signal peptide cleavage sites in amino 105 
acid sequences. (http://www.cbs.dtu.dk/services/SignalP-4.1) [17]. The CCTOP 106 
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(Constrained Consensus TOPology prediction server) web application provided 107 
prediction of the transmembrane protein topology (http://cctop.enzim.ttk.mta.hu) [18]. 108 
At the next stage of work, 12 isolates isolated from different regions of the 109 
Russian Federation in 2016 and 15 strains belonging to different genotypes [19, 20] and 110 
serotypes of the ASFV [21] were selected from the State Collection of Microorganisms 111 
of the FRCVM. For each seroimmunotype, attenuated and virulent ASFV strains are 112 
used as indicated in the table. 113 
Selection of primers for the copies amplification of the A238l, I329l and Dp71l 114 
genes was carried out by comparing and analyzing the nucleotide sequences of these 115 
genes from strains and various ASFV isolates published in the international GenBank 116 
database (http://www.ncbi.nlm.nih.gov/) using BioEdit 7.0.1, Oligo 6.0. and the IDT 117 
DNA web server (https://eu.idtdna.com/site). 118 
DNA extraction from blood and organ suspension was performed using DNA-119 
sorb-B kit («Interlabservice», Russia) in accordance with the manufacturer's 120 
instructions. Thermal cycler T100 («Bio-Rad Laboratories», USA) was used to optimize 121 
the temperature regimes of PCR and gene sequences amplification.  122 
Analysis of the reaction products was carried out by electrophoresis in 1.5% 123 
agarose gel and taken into account on ChemiDoc MP («Bio-Rad Laboratories», USA) 124 
by detection specific bands in the tracks with test samples relative to the molecular 125 
weight marker fragment and the calculated length of the PCR product. PCR products 126 
purification from agarose gel was performed by QIAquick Gel Extraction (QIAGEN) 127 
and Cleanup - standard («Evrogen», Russia) commercial kit. The sequencing reaction 128 
was performed using the Bigdye terminator v3.1 cycle sequencing kit («Applied 129 
Biosystems», USA). Genetic Analyzer 3130 sequencer ("Applied Biosystems", USA) 130 
was used for sequencing. 131 
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Multiple alignment of ASFV gene sequences was performed using variants of 132 
the ClustalW method and MUSCLE [22]. To construct phylogenetic trees, the 133 
maximum likelihood method was used with an additional bootstrap - analysis of 1000 134 
random samples using the Mega 6.0 program [23]. 135 
For the analysis of synonymous (synonymous distance, dS) and non-136 
synonymous substitutions (non-synonymous distance, dN) per site in the A238l, I329l 137 
and Dp71l genes, as well as the number of potentially synonymous and non-138 
synonymous sites for each codon based on the hypothesis of equal frequencies of all 139 
nucleotide substitutions, the SNAP (Synonymous Non-synonymous Analysis Program) 140 
software package was used (www.hiv.lanl.gov). 141 
 142 
Results and discussion 143 
The results of the proteins 5EL, I14L and K11L variability analysis of different 144 
ASFV strains showed that the 5EL protein has 13 variable sites, some of which are 145 
located in the region of IκB - a similar domain consisting of 3 ankyrin repeats (from 87 146 
to 178 amino acids) and C - terminal end of the PxIxITxC/S motif, which binds the 147 
catalytic subunit of calcineurin - serintreonin phosphatase (from 200 to 213 amino 148 
acids) (fig. 1). The ankyrin repetitive proteins although absent in most viruses, are also 149 
common among poxviruses. Conservative amino acid residues of ankyrins are crucial 150 
for folding and protein stability, and are also involved in the attachment of other 151 
proteins to different parts of the cell membrane [24].  152 
Analysis of the I14L protein shows that this protein is conservative among the 153 
different ASFV strains, but has 7 variable sites. All proteins encoded by this gene 154 
contain a central region with a highly conserved 56-amino acid domain and a PP1c_bdg 155 
motif (from 7 to 57 amino acids in short form and from 123 to 170 amino acids in long 156 
form) of the regulatory subunits (15A and 15B) of protein phosphatase 1, located at the 157 
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carboxyl end, common to MyD116 and ICP34.5. This conserved C-terminus appears to 158 
be the binding region of the catalytic subunit of protein phosphatase-1 (PP1C), which is 159 
found in both the herpes simplex virus and in mice and humans [25]. 160 
The highly glycosylated K11L protein expressed in the cell membrane and on its 161 
surface, containing leucine-rich repeats similar to TLR3, is conservative and has no 162 
pronounced variability. For him, there are only 8 variable sites, some of which fall into 163 
the extracellular topological domain (from 17 to 239 amino acid), as well as the 164 
intracellular topological domain (from 261 to 329 amino acid). The transmembrane 165 
region of the protein is located at the C-terminus (from 240 to 260 amino acids) (see fig. 166 
1).  167 
As a result of observations D. Chapman et al. the 5EL and I14L proteins are 168 
attributed to variable, in the work of V. de Oliveira et al. the K11L protein is 169 
conservative, and in the works of J. Neilan et al. and C. Abrams et al., the 5EL protein, 170 
on the contrary, was recognized as conservative [12, 26—28]. According to the results 171 
of our studies (see fig. 1), the studied proteins of the ASFV are conservative, especially 172 
in comparison with other ASFV variable proteins (CD2V, P54) [29]. 173 
In order to determine the genetic relationship at the nucleotide sequences level 174 
between ASFV strains and isolates, we performed sequencing and multiple alignment of 175 
the concatenated set of A238l, I329l and Dp71l genes. 176 
According to the sequencing results of the A238l and I329l genes of ASFV 177 
isolates, which were isolated on the Russian Federation territory in 2016, are identical to 178 
the Georgia_2007/1 parent strain, which is representative of the genotype II.  179 
According to the results obtained for the I329l gene, we can divide the existing 180 
isolates into 5 main clusters, which correlate with their genotypes (fig. 2). The first 181 
cluster includes strains from South-East Africa of genotype V, seroimmunotypes 3 and 182 
7, and full-genome isolates Warthog and Pretorisuskop/96/4 genotypes XIX and XX, 183 
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seroimmunotype 2. The second cluster consists of the representatives genotype II 184 
seroimmunotype 8 from the Russian Federation. A separate cluster contains strains of 185 
genotype I seroimmunotype 2. The fourth cluster consists of strains and isolates of 186 
European origin seroimmunotypes 1 and 4, with the exception of isolate Benin 97/1 of 187 
African origin belonging to genotype I. The fifth cluster included strains and isolates of 188 
genotype X isolated on the territory of Tanzania and Kenya, as well as some 189 
representatives of genotype VIII and IX. Isolates from South Africa and Portugal with 190 
indeterminate and seroimmunotype 2 were not included in any of the groups of listed 191 
clusters.    192 
An interesting fact is that in 6 East African strains of the genotype X (TKF, 193 
Nanyuki, TSP-80, TSP-80/300, TS-7, TS-7/27-230), as in the full-genome isolates 194 
Ken05/Tk1, Kenya 1950, Malawi Lil-20/1 and Ken06.Bus strain, the Dp71l gene is 195 
formed by fusing 13L and 14L. For example, the results of the detection of 2 forms 196 
amplification products of the Dp71l gene are shown in fig.3. The results of our studies 197 
confirm the previously obtained data R. Bishop et al. [30]. 198 
Earlier studies have shown that the method of concatenated genes can resolve 199 
ambiguities in phylogenetic constructions based on individual genes. The concatenation 200 
of large multigene data sets to improve the accuracy of phylogenetic inference is an 201 
accepted technique for clusters consisting of orthologous genes [3]. 202 
Concatenation is widely used in taxa in which there are complete genomes, for 203 
example, in prokaryotes [31] and taxa with small organelle genomes, such as animal 204 
mitochondria [32]. The sequence concatenation can hide the main tree of species with 205 
different phylogenetic signals in the evolution of individual genes [3].  206 
In our work, the amino acid sequences of three proteins 5EL, K11L, and I14L 207 
from 32 ASFV strains were concatenated into one pseudosequence and were used to 208 
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calculate the ratio of non-synonymous (dN) - synonymous substitution (dS) per site 209 
(dN/dS ratio).  210 
The number of synonymous substitutions on the synonymous site prevailed over 211 
the number of non-synonymous to a non-synonymous site 0.2788>0.0678 (dS> dN, pS> 212 
pN). When calculating the ratio dN/dS, the value is 0.2432<1. This indicates purifying 213 
(stabilizing) selection at the level of nucleotide sequences. 214 
Purifying selection occurs most frequently and is characteristic of nucleotide 215 
sequences encoding structurally functionally formed proteins. A comparison of the rates 216 
of synonymous and nonsynonymous substitutions for ASFV genes revealed from 14 to 217 
18 genes that are subject to positive selection [26]. The role of the immune system in 218 
relation to sequence variability can influence the sequences evolution of the ASFV 219 
some genes, which therefore can lead to a shift in the time to most recent common 220 
ancestor (TMRCA). Lower rates of non-synonymous changes are found in viruses 221 
transmitted by arthropod vectors, which reflects the increased cleansing selection 222 
pressure associated with replication in various host types. It is possible that many 223 
mutations that occur inside the host are removed during transmission between them due 224 
to the strong purifying selection, primarily due to the mismatch of the cytotoxic host 225 
immune response carried out by T-lymphocytes. 226 
In the work of E. de Villiers et al. 4 models of codon replacement (M1, M2, M7 227 
and M8) were investigated. The M2 model identified 14 ASFV genes under positive 228 
selection. These include proteins of the 360 and 505 multigenic families, several 229 
hypothetical proteins, a CD2v homologue, several enzymes and viral chaperone B602l 230 
which ensures the correct folding of the basic protein capsid P72. The strictest model 231 
for positive selection M8 identified eighteen genes, eight of which are under positive 232 
selection and are genes that can participate in modulating the host cell functions [3]. 233 
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Data analysis of the ratio of non-synonymous and synonymous mutations at a 234 
broad level of the genome show several genes that may be under selective pressure. 235 
 236 
Conclusion 237 
The range of group variability of proteins was previously studied by various 238 
groups of researchers on the example of the P17 proteins [34], P54 and CD2v [15, 26, 239 
33]. 240 
Characteristics of the ASFV genes variability of the selected group are object of 241 
great interest for searching for genetic differences and markers of evolutionary 242 
variability in immunomodulatory proteins and can also serve to identify target sites in 243 
the ASFV genome for vaccine development. 244 
The results obtained from bioinformatics analysis showed that the 5EL and I14L 245 
proteins have intracellular regions, the K11L protein has extracellular and intracellular 246 
topological domains and a transmembrane region. The presence of single nucleotide 247 
substitutions in these sites may indicate a greater conservatism of these proteins. 248 
The degree of nucleotide substitutions of the concatenated A238l, I329l and 249 
Dp71l ASFV genes, as determined in this study, revealed a purifying (stabilizing) 250 
selection at the level of the nucleotide sequences. As a result of the nucleotide 251 
sequences analysis obtained as a result of sequencing of the A238l, I329l and Dp71l 252 
genes, it can be concluded that these genes are conservative, with variable regions 253 
within them. All Russian ASFV isolates obtained in 2016-2017 have identical 254 
sequences of the A238l and I329l genes, which indicate their common origin. The 255 
topology of the phylogenetic tree according to the I329l gene completely corresponds 256 
with the phylogenetic tree constructed on the basis of a pseudosequence of 7 257 
immunomodulatory genes. Thus, the I329l gene may be a genetic marker of common 258 
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origin. ASFV I14L protein has two forms: a long one (184 amino acids) and a short one 259 
(from 70 to 72 amino acids), which is unique among the ASFV variants.  260 
Using the data obtained, it is possible to predict the possible involvement of 261 
these genes in changing the level of virulence inherent in the selected strains, as well as 262 
the ability to be factors for the ASFV virulence.  263 
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Fig.1. The results of the variability analysis of proteins 5EL - IkB homolog and 389 
inhibitor calceneurin phosphatase; I14L - a protein similar to HSV neurovirulence 390 
factor ICP34.5; K11L - a TLR signaling inhibitor protein. 391 
Fig.2. Phylogenetic dendrogram constructed by the maximum likelihood method 392 
based on concatenated nucleotide sequences of ASFV 15 strains of 7 393 
seroimmunotypes. The legend indicates the strains and isolates: - isolated 394 
from pigs, - ticks, - warthogs and - adapted to cell culture. 395 
Fig.3. Electrophoregram of the amplification products of the Dp71l gene encoding 396 
I14L protein. M = 100 b.p. 397 
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